WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world , today announced that Pascale Witz, MBA, MSc, has been elected to its Board of Directors, effective immediately.
“We would like to extend a warm welcome to Pascale as the newest member of our Board,” said Robert Friel, chairman and chief executive of PerkinElmer. “She brings a wide range of commercial healthcare and strategic management experience across the pharmaceutical, medical device, and diagnostics industries, and I am confident that her leadership will be invaluable in helping drive the future direction of the Company.”
Witz has more than 30 years of global experience, most recently serving as executive vice president, Global Diabetes and Cardiovascular for Sanofi, S.A. Prior to Sanofi, she held several leadership positions during her 17 years with GE Healthcare, including the role of president and CEO of its medical diagnostics division. She began her career in research before moving to a marketing role at Becton Dickinson France in 1991 and to GE Healthcare in 1996.
Witz currently serves on the Board of Directors of Horizon Pharma Plc, Regulus Therapeutics, Inc., Fresenius Medical Care AG & Co. KGaA, Savencia SA, and French-American Foundation-France. Witz received her MSc in biochemistry from the Institut National des Sciences Appliquées de Lyon, France and an MBA in economics and marketing from INSEAD, Fontainebleau, France.
About PerkinElmer, Inc.
PerkinElmer, Inc. is a global leader committed to innovating for a healthier world. Our dedicated team of 9,000 employees worldwide is passionate about providing customers with an unmatched experience as they help solve critical issues especially impacting the diagnostics, discovery and analytical solutions markets. Our innovative detection, imaging, informatics and service capabilities, combined with deep market knowledge and expertise, help customers gain earlier and more accurate insights to improve lives and the world around us. The Company reported revenue of approximately $2.1 billion in 2016, serves customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.